CLINICAL_TRIALS
trial_result
· 2012-04-30
Clinical Trial Update: A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia [Phase 2]
Summary
Phase II trial evaluating ofatumumab in Waldenström macroglobulinemia; the study has completed and results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Waldenstrom Macroglobulinaemia | Phase 2 | Status: COMPLETED | Results posted: 2012-04-30